Oncocyte Corp Annual Amortization of Intangible Assets in USD from 2014 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Oncocyte Corp quarterly/annual Amortization of Intangible Assets history and growth rate from 2014 to 2023.
- Oncocyte Corp Amortization of Intangible Assets for the quarter ending June 30, 2024 was $22K, unchanged year-over-year.
- Oncocyte Corp Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $88K.
- Oncocyte Corp annual Amortization of Intangible Assets for 2023 was $88K, a 97.6% decline from 2022.
- Oncocyte Corp annual Amortization of Intangible Assets for 2022 was $3.69M, a 9.85% increase from 2021.
- Oncocyte Corp annual Amortization of Intangible Assets for 2021 was $3.36M, a 4049% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)